相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI
Shan Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus
Zakir Khan et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone
Vickie Y. Jo et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients
Jiong Hu et al.
ONCOTARGET (2016)
Sp1 and the 'hallmarks of cancer'
Kate Beishline et al.
FEBS JOURNAL (2015)
WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition
Vickie Y. Jo et al.
PATHOLOGY (2014)
Myeloid cell leukemia-1 is a key molecular target for mithramycin A-induced apoptosis in androgen-independent prostate cancer cells and a tumor xenograft animal model
Eun-Sun Choi et al.
CANCER LETTERS (2013)
Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: A novel therapeutic agent for neuroblastoma
Don Eslin et al.
MOLECULAR CARCINOGENESIS (2013)
BIRC5 Expression Is a Poor Prognostic Marker in Ewing Sarcoma
Pooja Hingorani et al.
PEDIATRIC BLOOD & CANCER (2013)
Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study
Don Eslin et al.
TUMOR BIOLOGY (2013)
Inhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo
Shuang Yan et al.
ONCOTARGET (2013)
Mithramycin A Inhibits Myeloid Cell Leukemia-1 to Induce Apoptosis in Oral Squamous Cell Carcinomas and Tumor Xenograft through Activation of Bax and Oligomerization
Ji-Ae Shin et al.
MOLECULAR PHARMACOLOGY (2013)
Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma
B. Greve et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
Interplay of Posttranslational Modifications in Sp1 Mediates Sp1 Stability during Cell Cycle Progression
Yi-Ting Wang et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Identification of an Inhibitor of the EWS-FLI1 Oncogenic Transcription Factor by High-Throughput Screening
Patrick J. Grohar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met
Sabitha Papineni et al.
CARCINOGENESIS (2009)
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression
Santhi Konduri et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells
Pierre-Olivier Esteve et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation
Maen Abdelrahim et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Survivin, a cancer target with an emerging role in normal adult tissues
Seiji Fukuda et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Multiple roles of COX-2 in tumor angiogenesis: A target for antiangiogenic therapy
S Gately et al.
SEMINARS IN ONCOLOGY (2004)
Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma
B Fuchs et al.
CLINICAL CANCER RESEARCH (2004)
Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications
AS Tarnawski et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
Ewing's sarcoma: diagnostic, and therapeutic implications of molecular abnormalities
SA Burchill
JOURNAL OF CLINICAL PATHOLOGY (2003)
Transcription factors as targets for cancer therapy
JE Darnell
NATURE REVIEWS CANCER (2002)
分享论文
